Clinical Trials for Advanced Solid Tumors Harboring MAPK Pathway Alterations

Find clinical trials for advanced solid tumors harboring mapk pathway alterations. Discover research opportunities and treatment options in your area.

1 Active Trial Found

Showing 1 trial on this page

Page 1 of 1

Safety, Tolerability and Pharmacokinetics Study of QLH11906 in Patients With Advanced Solid Tumors Harboring MAPK Pathway Alterations.

NCT ID: NCT05488821

This clinical trial is studying a new treatment called QLH11906 for patients with advanced solid tumors that have changes in a specific signaling pathway known as MAPK. The main goal of the trial i...

Recruiting

Phase: PHASE1 Type: interventional Locations: Shandong, , China

Related Conditions

Breast Cancer View clinical trials → Stroke View clinical trials → Obesity View clinical trials → Cancer View clinical trials → Healthy View clinical trials → Prostate Cancer View clinical trials →

Search All Trials Browse All Conditions